Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.

Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.

Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.

Neuropsychobiology. 2009;60(1):23-30. doi: 10.1159/000234814. Epub 2009 Aug 14.

PMID:
19684420
2.

Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.

Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.

Depress Anxiety. 2003;17(1):43-8.

PMID:
12577277
3.

Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.

Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.

Psychopharmacology (Berl). 2006 Jul;186(4):601-11. Epub 2006 Apr 22.

PMID:
16758243
4.

The combined DEX-CRH test in treatment course and long-term outcome of major depression.

Hatzinger M, Hemmeter UM, Baumann K, Brand S, Holsboer-Trachsler E.

J Psychiatr Res. 2002 Sep-Oct;36(5):287-97.

PMID:
12127596
5.

Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.

Psychopharmacology (Berl). 2005 Oct;181(4):751-60. Epub 2005 Sep 29.

PMID:
15988572
6.

Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.

Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.

J Psychiatr Res. 2008 Oct;42(14):1154-62. doi: 10.1016/j.jpsychires.2008.01.005. Epub 2008 Feb 20.

PMID:
18281062
7.

Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.

Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S230-4. Review.

PMID:
14677084
8.

Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.

Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.

J Psychiatr Res. 2003 Mar-Apr;37(2):135-43.

PMID:
12842167
9.

Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.

Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.

Psychoneuroendocrinology. 2009 Feb;34(2):238-48. doi: 10.1016/j.psyneuen.2008.09.004. Epub 2008 Oct 15.

PMID:
18926641
10.

Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response.

Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E.

J Psychiatr Res. 2004 Sep-Oct;38(5):453-65.

PMID:
15380395
11.

Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.

Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.

J Psychiatr Res. 2001 Jul-Aug;35(4):239-47.

PMID:
11578642
12.

Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.

Schüle C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Möller HJ, Rupprecht R.

Psychopharmacology (Berl). 2003 Mar;166(3):271-5. Epub 2003 Jan 28.

PMID:
12552362
13.

Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.

Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.

Psychoneuroendocrinology. 2008 Feb;33(2):152-61.

PMID:
18068306
14.

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.

Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M.

J Psychiatr Res. 2001 Mar-Apr;35(2):83-94.

PMID:
11377437
15.

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.

Rybakowski JK, Twardowska K.

J Psychiatr Res. 1999 Sep-Oct;33(5):363-70.

PMID:
10504004
16.

HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.

Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.

Psychoneuroendocrinology. 2009 Jan;34(1):99-109. doi: 10.1016/j.psyneuen.2008.08.018. Epub 2008 Sep 30.

PMID:
18829172
17.
18.

Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.

Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.

Neuropsychopharmacology. 2002 Sep;27(3):470-8.

19.

Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.

Baghai TC, Schule C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R.

Neurosci Lett. 2002 Aug 16;328(3):299-303.

PMID:
12147330
20.

Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?

Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.

Biol Psychiatry. 2007 Jul 1;62(1):47-54. Epub 2006 Nov 21.

PMID:
17123470
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk